Noteworthily, increased brain levels of FNDC5/irisin restored synaptic plasticity and prevented memory impairment, suggesting that increasing irisin levels, either pharmacologically or through exercise, is a new therapeutic strategy to counteract cognitive decline in AD [30]. This evidence concerns the gene FNDC5 and Alzheimer disease.